Trial Profile
An Open-label Switch Study to Asenapine in the Early Stage of Psychosis
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Asenapine (Primary)
- Indications Schizoaffective disorder; Schizophrenia; Schizophrenia and disorders with psychotic features
- Focus Therapeutic Use
- Acronyms SWITCH-Asenapine
- 30 Oct 2013 New trial record